Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-28T03:30:13.205Z Has data issue: false hasContentIssue false
  • English
  • Français

Amiodarone for post-operative junctional ectopic tachycardia

Published online by Cambridge University Press:  14 April 2005

Kevin Plumpton ,
Robert Justo  and
Nikolaus Haas
Kevin Plumpton
Affiliation:
Paediatric Cardiac Intensive Care Unit, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
Robert Justo
Affiliation:
Paediatric Cardiac Intensive Care Unit, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
Nikolaus Haas
Affiliation:
Paediatric Cardiac Intensive Care Unit, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Post-operative junctional ectopic tachycardia is a transient, but potentially life threatening, rapid automatic tachyarrhythmia that requires urgent and adequate treatment. In our study, we review retrospectively the use and efficacy of amiodarone for this arrhythmia over an 8-year period in our institution. Methods and patients: Retrospective review revealed 15 patients who were administered amiodarone for post-operative junctional ectopic tachycardia during the period. The median age was 2.6 months, with a range from 8 days to 8.1 months. The median weight was 4.6 kilograms, with a range from 2.6 to 8.2 kilograms. Results: The median heart rate at diagnosis of the tachycardia was 192 beats per minute, and the range was 182 to 229 beats per minute. The biochemistry was essentially normal. The median length of time until the tachycardia was controlled was 4.5 hours, and the range was from 1 to 19.5 hours, with 13 of the 15 patients controlled within 12 hours. The median dose of amiodarone received by this time was 5.9 milligrams per kilogram, with a range from 1.0 to 25.0 milligrams per kilogram. Hypotension or bradycardia within 4 hours of commencing amiodarone were noted in 2 patients. Conclusion: Experience in our institution, and a review of the literature, suggests that the most rapid control of post-operative junctional ectopic tachycardia will be obtained by a bolus of amiodarone followed by an intravenous infusion. Intravenous amiodarone is generally safe, with few side effects. Reported life threatening arrhythmias, however, suggest that intravenous amiodarone should be restricted to a setting where invasive monitoring and external cardiac pacing are available.

Keywords

Congenital heart diseasepaediatric intensive carearrhythmiaelectrophysiology
Type
Original Article
Information
Cardiology in the Young , Volume 15 , Issue 1 , January 2005 , pp. 13 - 18
Copyright
2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dodge-Khatami A, Miller OI, Anderson RH, Gil-Jaurena JM, Goldman AP, de Leval MR. Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects. Eur J Cardiothorac Surg 2002; 21: 255–259.Google Scholar
Hoffman TM, Bush DM, Wernovsky G, et al. Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg 2002; 74: 1607–1611.Google Scholar
Raja P, Hawker RE, Chaikitpinyo A, et al. Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Br Heart J 1994; 72: 261–265.Google Scholar
Perry JC, Fenrich AL, Hulse JE, Triedman JK, Friedman RA, Lamberti JJ. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol 1996; 27: 1246–1250.Google Scholar
Laird WP, Snyder CS, Kertesz NJ, Friedman RA, Miller D, Fenrich AL. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia in children. Pediatr Cardiol 2003; 24: 133–137.Google Scholar
Gandy J, Wonko N, Kantoch MJ. Risks of intravenous amiodarone in neonates. Can J Cardiol 1998; 14: 855–858.Google Scholar
Celiker A, Ceviz N, Ozme S. Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children. Acta Paediatr Jpn 1998; 40: 567–572.Google Scholar
Yap SC, Hoomtje T, Sreeram N. Polymorphic ventricular tachycardia after use of intravenous amiodarone for postoperative junctional ectopic tachycardia. Int J Cardiol 2000; 76: 245–247.Google Scholar
Haas NA, Plumpton K, Justo R, Jalali H, Pohlner P. Postoperative junctional ectopic tachycardia (JET). Z Kardiol 2004; 93: 371–380.Google Scholar
Lan YT, Lee JC, Wetzel G. Postoperative arrhythmia. Curr Opin Cardiol 2003; 18: 73–78.Google Scholar
Walsh EP, Saul JP, Sholler GF, et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997; 29: 1046–1053.Google Scholar
MIMS online. Sydney, NSW: Hcn.; 2004.
England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992; 268: 2395–2402.Google Scholar
Fox ML, Burrows FA, Reid RW, Hickey PR, Laussen PC, Hansen DD. The influence of cardiopulmonary bypass on ionized magnesium in neonates, infants, and children undergoing repair of congenital heart lesions. Anesth Analg 1997; 84: 497–500.Google Scholar
Wilkes NJ, Mallett SV, Peachey T, Di Salvo C, Walesby R. Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 2002; 95: 828–834 (Table of Contents).Google Scholar
Yurvati AH, Sanders SP, Dullye LJ, Carney MP, Archer RL, Koro PP. Antiarrhythmic response to intravenously administered magnesium after cardiac surgery. South Med J 1992; 85: 714–717.Google Scholar
Casthely PA, Yoganathan T, Komer C, Kelly M. Magnesium and arrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1994; 8: 188–191.Google Scholar
Dorman BH, Sade RM, Burnette JS, et al. Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects. Am Heart J 2000; 139: 522–528.Google Scholar
Dittrich S, Germanakis J, Dahnert I, et al. Randomised trial on the influence of continuous magnesium infusion on arrhythmias following cardiopulmonary bypass surgery for congenital heart disease. Intensive Care Med 2003; 29: 1141–1144.Google Scholar